市場調查報告書
商品編碼
1446993
2030 年冷泡泡棉泡殼包裝市場預測:按材料、應用和地區分類的全球分析Cold Form Blister Packaging Market Forecasts to 2030 - Global Analysis By Material (Polypropylene, Aluminum, Oriented Polyamide, Polyvinyl Chloride, Polyethylene, Polyethylene Terephthalate and Other Materials), Application, and By Geography |
根據 Stratistics MRC 的數據,2023 年全球冷成型泡殼包裝市場規模為 42.1 億美元,預計到 2030 年將達到 75.4 億美元,預測期內年複合成長率為 8.7%。
冷成型泡殼包裝是一種包裝藥品和其他精緻產品的方法,其中泡殼在室溫下形成而不是預先成型。它需要 PVC、鋁和冷泡沫箔的組合,通常由鋁和塑膠層的組合組成。與熱成型泡殼相比,冷成型可實現更深的腔體、更複雜的設計以及更高的阻隔性。這種包裝技術廣泛應用於製藥業,因為它可以保持產品穩定性並延長保存期限。
根據國際藥品製造商協會聯合會統計,2020年共有53種新藥上市,目前全球有超過9,000種化合物處於不同開發階段。
製藥業的成長
冷泡泡泡殼包裝因其高阻隔阻隔性而廣泛應用於製藥領域,以確保敏感藥品的安全、完整和保存。隨著製藥業在全球範圍內不斷擴張,對冷泡沫泡殼包裝的需求不斷增加。此外,這些行業強調遵守嚴格的監管標準,例如美國FDA 和歐洲藥品管理局 (EMA),進一步推動了冷成型泡殼包裝的採用。
初始投資高
投資能夠生產高品質冷成型泡殼包裝的最先進的機械需要大量的初始投資。這些機器很複雜,需要專門知識來操作和維護,進一步增加了初始投資負擔。此外,包括鋁箔和特種層壓板在內的原料採購可以進一步影響該市場的投資計劃和盈利。
技術進步
技術進步涵蓋製造流程、材料和設計能力的各個方面,有助於提高產品品質、效率和客製化。我們的設計能力允許對冷成型泡殼包裝進行客製化和個性化。此外,創新的印刷技術實現了複雜的設計、品牌、序列化和監管要求,這是推動這一市場規模的一個因素。
缺乏意識
製藥和醫療保健行業的製造商和相關人員可能沒有接受過有關冷成型泡殼包裝的良好教育。如果沒有足夠的教育,公司可能會忽略冷成型泡殼包裝是滿足其包裝需求的可行解決方案,或者可能難以有效實施。此外,消費者可能缺乏對冷成型泡殼包裝所提供的好處的認知,這可能會進一步阻礙該市場。
COVID-19 的影響
COVID-19大流行為冷泡沫泡殼包裝市場帶來了各種挑戰。疫情擾亂了全球供應鏈和製造營運,導致供應鏈中斷、原料短缺和物流挑戰。此外,嚴格的封鎖措施和社交距離規定阻礙了業務營運,導致計劃延遲並減少了包裝技術和基礎設施升級的投資,可能會影響我提供的冷成型泡殼包裝的需求。
預計聚氯乙烯(PVC) 領域在預測期內將成為最大的領域
聚氯乙烯(PVC)部分預計將佔據最大佔有率,因為它在為包裝過程提供基本功能方面發揮著重要作用。 PVC 是一種熱塑性聚合物,以其多功能性、耐用性和成本效益而聞名,使其成為泡殼包裝的首選材料。此外,這些薄膜通常堅硬、耐刺穿,並且在包裝過程中在相對較低的溫度下易於熱成型,從而推動了該領域的成長。
預計醫療保健產業在預測期內年複合成長率最高
由於醫療保健行業對產品保護、砸道機和患者安全的嚴格要求,預計在預測期內年複合成長率最高。醫療保健產品,尤其是藥品,需要免受水分、氧氣和光線等環境因素的影響,以保持其有效性和穩定性。此外,醫療保健行業經常處理各種形狀和尺寸的產品,需要軟包裝解決方案,這正在推動該領域的成長。
在估計期間,歐洲佔據了最大的市場佔有率,因為冷泡沫泡殼包裝在各行業(主要是製藥和醫療保健)的採用不斷增加。此外,一些領先公司越來越依賴冷成型泡殼包裝,因為其卓越的阻隔性能可確保敏感藥物免受濕氣、氧氣和污染。此外,該地區人口老化和慢性病盛行率上升進一步增加了市場需求。
預計北美在預測期內的年複合成長率最高,因為它使用具有阻隔性的專用鋁基層壓板,適合保護敏感的藥品和保健產品。此外,在北美,FDA 等監管機構對包裝和標籤實施了嚴格的規定,這也有助於冷成型泡殼包裝的採用並支持在該地區的擴張。
According to Stratistics MRC, the Global Cold Form Blister Packaging Market is accounted for $4.21 billion in 2023 and is expected to reach $7.54 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Cold form blister packaging is a method of packaging pharmaceuticals and other sensitive products where the blister is formed at room temperature rather than being pre-formed. It involves a combination of PVC, aluminum, and a cold-form foil, typically composed of aluminum with a layer of plastic. Cold forming allows for deep cavities, intricate designs, and improved barrier properties compared to thermoformed blisters. This packaging technique is widely used in the pharmaceutical industry for its ability to maintain product stability and extend shelf life.
According to the International Federation of Pharmaceutical Manufacturers & Associations, in 2020, 53 new medicines were launched, while currently, more than 9,000 compounds are at different stages of development globally.
Pharmaceutical industry growth
Cold form blister packaging is extensively utilized in the pharmaceutical sector for its ability to provide high barrier properties, ensuring the safety, integrity, and shelf-life of sensitive drugs. As the pharmaceutical industry continues to expand globally, the demand for cold form blister packaging rises. Moreover, these industries' emphasis on compliance with stringent regulatory standards, such as those imposed by the FDA in the United States and the European Medicines Agency (EMA) in Europe, further drives the adoption of cold form blister packaging.
High initial investment
Investing in state-of-the-art machinery capable of producing high-quality cold form blister packaging involves significant upfront costs. These machines are complex and require specialized knowledge for operation and maintenance, further adding to the initial investment burden. Moreover, the procurement of raw materials, including aluminum foil and specialized laminates, can further impact investment planning and the profitability of this market.
Technological advancements
Advancements encompass various aspects of manufacturing processes, materials, and design capabilities, contributing to the enhancement of product quality, efficiency, and customization. Their design capabilities allow for greater customization and personalization of cold form blister packaging. Furthermore, innovative printing technologies enable intricate designs, branding, serialization, and regulatory requirements, which thereby drive this market size.
Lack of awareness
Manufacturers and stakeholders within the pharmaceutical and healthcare industries may lack sufficient education about cold form blister packaging. Without adequate education, companies may overlook cold form blister packaging as a viable solution for their packaging needs or may struggle to implement it effectively. Additionally, consumers may also lack awareness of the advantages offered by cold form blister packaging, which can impede this market further.
Covid-19 Impact
The COVID-19 pandemic has presented various challenges to the cold-form blister packaging market. As the pandemic disrupted global supply chains and manufacturing operations, it led to supply chain disruptions, raw material shortages, and logistical challenges. Additionally, stringent lockdown measures and social distancing regulations hindered business operations, leading to project delays and decreased investments in packaging technologies and infrastructure upgrades, potentially impacting the demand for cold-form blister packaging.
The polyvinyl chloride (PVC) segment is expected to be the largest during the forecast period
The polyvinyl chloride (PVC) segment is estimated to hold the largest share due to its crucial role in providing essential features to the packaging process. It is a thermoplastic polymer known for its versatility, durability, and cost-effectiveness, making it a preferred material for blister packaging. Additionally, these films are typically rigid and resistant to punctures and can be easily thermoformed at relatively low temperatures during the packaging process, thereby boosting this segment's expansion.
The healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment is anticipated to have highest CAGR during the forecast period due to its stringent requirements for product protection, tamper resistance, and patient safety. Healthcare products, particularly pharmaceuticals, require protection from environmental factors such as moisture, oxygen, and light to maintain their efficacy and stability. Moreover, the healthcare industry often deals with a wide range of product shapes and sizes, requiring a flexible packaging solution, which is driving this segment's growth.
Europe commanded the largest market share during the extrapolated period owing to increased adoption of cold form blister packaging across various industries, particularly pharmaceuticals and healthcare. Some of the major players are also increasingly relying on cold form blister packaging due to its superior barrier properties, ensuring the protection of sensitive drugs from moisture, oxygen, and contamination. In addition, the region's growing aging population and the rising prevalence of chronic diseases have further fueled the demand for this market in this region.
North America is expected to witness highest CAGR over the projection period, owing to the use of a special aluminum-based laminate that provides high barrier properties, making it suitable for protecting sensitive pharmaceuticals and healthcare products. Moreover, in North America, the stringent regulations imposed by regulatory bodies such as the FDA regarding packaging and labeling also contributed to the adoption of cold-form blister packaging, which is thereby propelling this region's expansion.
Key players in the market
Some of the key players in the Cold Form Blister Packaging Market include UFlex Limited, Amcor plc, SteriPackGroup, Constantia Flexibles, Sonoco Products Company, WestRock Company, Honeywell International Inc, Klockner Pentaplast, ACG, Bilcare Limited, Svam Toyal Packaging Industries Pvt. Ltd., Tekni-Plex, Inc., Essentra plc, Ningbo Dragon Packaging Technology Co., Ltd. And Wasdell Group.
In January 2024, Amcor announced a significant expansion of its North American thermoforming capabilities for the healthcare market.
In December 2023, Honeywell announced plans to enhance and strengthen its building automation capabilities with the acquisition of Carrier Global Corporation's Global Access Solutions business for $4.95 billion, in an all-cash transaction.
In September 2023, Amcor announced the North American launch of curbside-recyclable AmFiber(TM) Performance Paper packaging, part of the company's AmFiber portfolio.